Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Amber Meskens

Publications & Research Data

Awards & Distinctions

3 Results

2025

Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice

Amber MeskensSara NeytMichaël HenrotteJens DebackerChristian VanhoveFilip De Vos

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Michaël HenrotteDavid CreytensFilip De VosBenedicte DescampsLindsey DevisscherGabriële HoltappelsWouter HuvenneKen KersemansAmber MeskensSara Neyt et al.

Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model

Michaël HenrotteDavid CreytensFilip De VosBenedicte DescampsLindsey DevisscherWouter HuvenneKen KersemansAmber MeskensChristian VanhoveJens Debacker